David Luke
Strategic Advisor @Arch Biopartners Inc Arch Tsxv Achff Otcqb
Signup · Get unlimited contacts
WORK HISTORY
Strategic Advisor @Arch Biopartners Inc Arch Tsxv Achff Otcqb
Toronto, ON, CA
Working alongside Richard Muruve, CEO and Daniel Muruve, MD and CMO at Arch Biopartners, we are developing the regulatory strategy and clinical development of the novel immunomodulator, LSALT peptide for the prevention of COVID-19-related complications, including ARDS, AKI, cardiomyopathies, acute liver injury, coagulopathies, and all-cause mortality. We have developed a Phase 2 protocol (NCT04••••57) and the associated ICF and IB, for submission and acknowledgment of a CTA in Canada and IND in the US - all within 3 months. The study successfully completed in April 2021. We are now initiating a study in preventing acute kidney injury following cardiac surgery (NCT05••••32) and entered our first 2 patients in March 2024.
EDUCATION
University of Toronto
Bachelor of Science
University of Toronto
BSc Pharmacy, Pharmacy
University of the Sciences in Philadelphia
PharmD, Clinical Pharmacy
University of Toronto
BScPhm, Pharmacy
University of Minnesota
Fellow, Infectious Diseases and Nephrology
University of the Sciences in Philadelphia
Doctor of Pharmacy, Pharmacy
York University
Bachelor of Arts
University of Minnesota
Fellowship, Infectious Diseases and Nephrology
SKILLS
ABOUT DAVID LUKE
I have extensive experience leading and executing development plans and studies for all phases of drug development from preclinical through Phase 3, including 25+ INDs, 18 US and global regulatory submissions, 16 product launches, and life cycle management following these launches. I have broad experience managing multi-million dollar budgets, optimizing timelines and resources, and product strategy plans. Main therapeutic areas of expertise are infectious diseases, nephrology, neurosciences, diabetes, pulmonary, immunology, and pharmacokinetics/pharmacology. I am a pharmaceutical research consultant currently working closely with large PhRMA and biotech companies in infectious diseases, nephrology, neurosciences, immunology, and diabetes based in the US, Canada, and globally - D••••••••@gmail.com
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.